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Abstract The ability to repair DNA interstrand cross-links may
be an important factor contributing to mitomycin C (MMC) and
cisplatin cytotoxicities. We have assessed the repair of inter-
strand cross-links induced by MMC in two MMC-hypersensitive
hamster cell mutants and their resistant parental cell line. Using
a gene-specific repair assay, we found no evidence for repair of
MMC cross-links in either parental or mutant cells, suggesting
that persistence of DNA interstrand cross-links is not responsible
for the differential toxicity of MMC towards hypersensitive
cells. Repair of cisplatin-induced interstrand cross-links was
efficient in resistant as well as in mutant cells. Therefore we
concluded that a defect in excision repair of interstrand cross-
links was not responsible for the cytotoxic effects of MMC and
cisplatin in these hypersensitive mutants.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Interstrand DNA cross-links represent an important class
of chemical damage to DNA, since they prevent DNA strand
separation and thus can constitute complete blocks to DNA
replication and transcription. Since cross-linking of DNA has
been considered to be responsible for cytotoxicity, a number
of bifunctional agents such as cisplatin, mitomycin C, and
nitrogen mustard have been used extensively in cancer chemo-
therapy, as single agents or in combination in the treatment of
a wide variety of malignant tumors [1].
Cisplatin and mitomycin C (MMC) are both structurally
and chemically distinct. Cisplatin preferentially forms lesions
at the N-7 position of guanine [2], whereas MMC mainly
alkylates the N-2 position of guanine, upon reductive activa-
tion cascade [3]. Cisplatin can generate intra- and interstrand
cross-links, both of which have been implicated in cytotoxicity
[4,5]. In contrast, the toxicity of MMC has been mainly cor-
related with the formation of interstrand cross-links [3].
Although most of the chemical lesions produced by these
anticancer drugs are known, the molecular basis of their anti-
tumor activity is still to be understood. DNA repair e⁄ciency
and inhibition of DNA synthesis [6], as well as cell-cycle
checkpoint responses and induction of cell death by apoptosis
[7], have been considered the critical steps in toxicity.
To elucidate the mechanisms of the mammalian cell defence
against cross-linking agents, mutants speci¢cally sensitive to
MMC have been isolated in rodent cells [8]. The genetic and
biochemical complexity of these processes is re£ected by the
existence of at least eight complementation groups identi¢ed
among rodent cell mutants defective in this response [9,10]. V-
H4 and V-C8 cell mutants are representatives of two di¡erent
complementation groups and were isolated from V79 Chinese
hamster cells [11,12].
The V-H4 mutant cell line shows many typical character-
istics of cells derived from Fanconi anemia (FA) patients
[11,13]. V-H4 cells exhibit increased sensitivity towards
cross-linking agents such as MMC, cisplatin, and diepoxybu-
tane (DEB), but are not sensitive to UV light and X-rays [12].
The V-C8 mutant cell line also shows increased sensitivity
towards cross-linking agents, such as MMC, cisplatin, and
DEB, but is only slightly sensitive to UV and X-rays [12].
This combined analysis of the response of V-H4 and V-C8
cells to a panel of cytotoxic agents suggests that the defective
proteins in these cells are involved in cellular responses to
cross-linking agents such as MMC and cisplatin.
To assess whether a repair defect is involved in the speci¢c
hypersensitivity of V-H4 and/or V-C8 cells to bifunctional
agents, we have studied the formation and repair of MMC-
and cisplatin-induced DNA interstrand cross-links in these
mutants and their parental cell line V79. Interstrand cross-
links were detected at the level of the active and multi-copies
ribosomal RNA gene, using a gene-speci¢c repair assay
[14,15].
2. Materials and methods
2.1. Cells and culture conditions
The MMC-sensitive mutants V-H4 and V-C8 derived from Chinese
hamster V79 cells have been described previously [8,11,12]. V79, V-H4
and V-C8 cell lines were routinely grown in monolayer in Ham’s F-10
medium (Gibco) supplemented with 15% newborn calf serum (Gibco),
penicillin (100 U/ml), and streptomycin (0.1 Wg/ml). The Chinese ham-
ster AA8 cell line and its derived mutant UV4 from UV complemen-
tation group 1 were provided by Dr. D. Bush and have been described
previously [16]. AA8 and UV4 were routinely grown in monolayer in
KMEM medium (Gibco) supplemented with 10% fetal calf serum
(Gibco), penicillin (100 U/ml), and streptomycin (0.1 Wg/ml). All in-
cubations were at 37‡C in a humidi¢ed 5% CO2 atmosphere.
2.2. Cell treatments
For all experiments in this study, cells were in exponential growth
phase at the time of DNA damage. Cells were treated with MMC
(Sigma-Aldrich) for 1 h, or with cisplatin (Sigma-Aldrich) for 5 h, at
the indicated concentrations at 37‡C. After drug exposure, cells were
washed with phosphate-bu¡ered saline (PBS) and then incubated in
fresh medium. In each case, control and treated cells were handled in
the same way, with the only di¡erence being omission of the drug
treatment.
2.3. Cytotoxicity assay
Sensitivity to MMC was assessed in a colony-forming growth assay.
Cells were plated at various dilutions 1 day prior to treatment to
allow attachment. The attached cells were then treated with di¡erent
concentrations of MMC for 1 h at 37‡C. After drug treatment, cells
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were rinsed twice in PBS, and fresh medium was added. The cells were
allowed to grow for 8 days and were then ¢xed and stained in meth-
ylene blue solution (0.25%) and counted. The colony-forming e⁄cien-
cies of the V79, V-H4 and V-C8 cells were routinely 80%, 65% and
50%, respectively. Drug treatments were done in triplicate at each
concentration and the cell survival was expressed relative to the num-
ber of colonies obtained without drug.
2.4. Gene-speci¢c repair assay
A denaturation-renaturation gel electrophoresis method was used to
detect DNA interstrand cross-links induced by MMC or cisplatin
[14,15]. Cellular DNA was prelabeled by allowing cells to grow for
64 h at 37‡C in [methyl-3H]thymidine at 0.3 WCi/ml and 10 WM thy-
midine. Following this procedure, the cells were subcultured and in-
cubated in label-free medium for 24 h. Cells were then treated with 30
WM MMC for 1 h or with 200 WM cisplatin for 5 h. After drug
exposure, cells were washed twice with PBS, and lysed either imme-
diately or after repair incubation in a solution of 0.5 M Tris pH 8.0,
20 mM EDTA, 10 mM NaCl, 1% SDS and 0.5 mg/ml proteinase K
for 16 h at 37‡C. Cells used for repair analysis were incubated for 24
or 48 h at 37‡C in medium supplemented with 10 WM bromodeoxy-
uridine and 1 WM £uorodeoxyuridine to density label the DNA re-
plicated after MMC or cisplatin treatment. High molecular weight
DNA was isolated and puri¢ed by a salt lysis method [17], and then
restricted with HindIII (Biolabs) restriction endonuclease (2 U/Wg
DNA) and treated with 10 Wg/ml RNase A for 3^4 h. Samples were
centrifuged to equilibrium in a neutral CsCl gradient containing 10
mM Tris-HCl, 1 mM EDTA, pH 8.0 (TE). Fractions of parental and
replicated DNA were then pooled separately, dialyzed and resus-
pended in TE.
After treatment in 50 mM NaOH for 20 min at 37‡C, cross-linked
DNA was resolved from single-stranded DNA on a 0.6% agarose gel
at 30 V for 16^18 h. The DNA was transferred after electrophoresis to
Sureblot nylon membrane (Oncor, Appligene) in 1 M NaOH. The
membranes were prehybridized in Hybrisol I (Oncor), hybridized
with 32P-labeled DNA probe and then quanti¢ed using a Phosphor-
Imager (Molecular Dynamics Inc.) and ImageQuant software (Molec-
ular Dynamics Inc.). The 1.4-kb human 28S genomic probe (pABB)
for the ribosomal RNA gene is homologous to the hamster sequence
[18] and was used to detect a 20-kb HindIII fragment containing the
5.8S and 28S rRNA sequences in hamster cells. The degree of cross-
linking was calculated from the ratio of double-stranded to total
DNA in each lane. The Poisson distribution was applied to calculate
the average number of cross-links (=3Ln (fraction of molecules free
of cross-links)). Data were generated from three to ¢ve biological
experiments with three to six gels per experiment.
3. Results
3.1. Cell survival after MMC treatment
To con¢rm the hypersensitivity of the mutant cell lines to-
wards cross-linking agents in our repair assay conditions, we
determined the MMC cytotoxicity in these cell lines. The sur-
vival curves of parental V79 and mutant V-H4 and V-C8 cells
treated for 1 h with increasing concentrations of MMC are
presented in Fig. 1. The IC90 values (dose required to reduce
cell survival to 10%) of V79, V-H4 and V-C8 are 15 WM, 0.45
WM and 0.15 WM respectively (Fig. 1). Thus, we con¢rmed
that the mutant cells are 30-fold (V-H4) and 100-fold (V-C8)
more sensitive to MMC treatment than the parental cell line
V79. Cisplatin cytotoxicity was also tested in our repair assay
conditions: V-H4 cells are 10-fold and V-C8 cells 40-fold
more sensitive to cisplatin treatment than V79 (data not
shown).
3.2. Formation and repair of DNA interstrand cross-links
induced by MMC
To assess whether a repair defect is involved in the hyper-
sensitivity of V-H4 and/or V-C8 cells to MMC, we examined
the removal of MMC-induced interstrand cross-links from the
rRNA gene in V79, V-H4 and V-C8 cells. The rRNA gene
high copy number is transcribed at very high rates in expo-
nentially growing cells. Interstrand cross-links were detected
by a denaturation-renaturation method, after Southern trans-
fer and hybridization, as described in Section 2.
To compare the repair characteristics of the parental and
mutant cell lines, cells were treated with equimolar concentra-
tions of drug (30 WM MMC) for 1 h. These concentrations of
MMC are comparable to those achieved in plasma of humans
(10 WM) [19]. Since we measured signi¢cant amounts of DNA
synthesis during the incubation following MMC treatment,
the subsequent gene-speci¢c repair assays were done sepa-
rately on parental DNA (P) or newly replicated DNA (R).
A representative autoradiogram, Fig. 2A, shows the forma-
tion (t = 0 h) and the processing (t = 24 h and 48 h) of MMC-
FEBS 20968 19-10-98
Fig. 1. Clonogenic assay following MMC treatment. The percent
cell survival of the parental V79 cells and its mutants V-H4 and V-
C8 is shown as a function of MMC dose. The data are derived
from two independent experiments done in triplicate for each MMC
concentration and are presented as mean values þ S.E.
Fig. 2. Formation and repair of MMC-induced interstrand cross-
links in the rRNA gene of hamster cells. A: Representative autora-
diogram of Southern blot of HindIII genomic fragments, isolated
from V79, V-H4 and V-C8 cell lines treated with 30 WM MMC for
1 h, and hybridized with 32P-labeled probe for the rRNA region. B:
Representative autoradiogram of Southern blot of HindIII genomic
fragments, isolated from AA8 and UV4 cell lines treated with 30
WM MMC for 1 h, and hybridized with 32P-labeled probe for the
rRNA region. Cross-link detection in parental DNA (P) and newly
replicated DNA (R) is shown following incubation at 0, 24, and 48
h with denaturation by NaOH. DS, double-stranded DNA. SS, sin-
gle-stranded DNA. Cont, non-damaged DNA. Data were generated
from ¢ve biological experiments with four to six gels per assay. The
degree of cross-linking was calculated from the ratio of double-
stranded to total DNA in each lane, using a PhosphoImager and
ImageQuant software (Molecular Dynamics Inc.).
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induced interstrand cross-links within a 20-kb fragment of the
rRNA gene of the parental DNA (P) and the newly replicated
DNA (R) of V79, V-H4 and V-C8 cells. The treatment in-
duced a comparable number of cross-links per fragment (0.1
cross-link/10 kb at time point t = 0 h) in the three cell lines
(Fig. 2A), suggesting that the bioactivation of MMC is similar
in resistant and sensitive cell lines. Surprisingly, no signi¢cant
removal of MMC interstrand cross-links from the parental
DNA (P) of the three cell lines was observed during the sub-
sequent incubation, since the amount of interstrand cross-
links remained constant at time points 0, 24 and 48 h (0.09^
1.2 cross-link/10 kb in parental DNA) (Fig. 2A).
Moreover, the MMC-induced cross-links originally formed
in parental DNA (P) were also associated with newly repli-
cated DNA (R) at time points 24 h and 48 h (Fig. 2A). The
presence of DNA interstrand cross-links in the replicated
DNA after MMC treatment might be a consequence of a
recombinational mechanism occurring during replication
past cross-links, or a conversion of monofunctional MMC
adducts to interstrand cross-links during the repair kinetics.
In order to test these hypotheses, we examined the removal of
interstrand cross-links induced by MMC from the rRNA gene
in a repair-pro¢cient hamster cell line AA8 and its UV-sensi-
tive repair-de¢cient mutant UV4. UV4 cells belong to com-
plementation group 1 and cannot excise bulky lesions from
DNA. AA8 and UV4 cell lines were thus treated with 30 WM
MMC for 1 h and interstrand cross-links were detected by
denaturation-renaturation assay. As shown previously for
V79, V-H4 and V-C8 cells, there was no removal of MMC-
induced interstrand cross-links from the parental DNA (P) of
AA8 and UV4 cells (Fig. 2B). Furthermore, cross-links were
also associated with newly replicated DNA (R) at time points
24 h and 48 h in these cells (Fig. 2B). Addition of the amount
of interstrand cross-links in parental (P) plus replicated (R)
DNA at time point 48 h displayed a higher quantity of cross-
links (0.2 cross-link/10 kb) than the initial amount of cross-
links induced at time point 0 h (0.1 cross-link/10 kb) in the
parental DNA (P) after the MMC treatment in repair-de¢-
cient UV4 cells (Fig. 2B). Since these cells cannot excise
MMC adducts, these ¢ndings demonstrate that there is prob-
ably a conversion of MMC-induced monofunctional adducts
to interstrand cross-links during the post-treatment incuba-
tion.
Finally, MMC cross-link repair e⁄ciencies could not be
quantitatively compared between resistant and hypersensitive
cell lines, since we measured a combination of formation and
removal of MMC interstrand cross-links during the repair
kinetics.
3.3. Formation and repair of DNA interstrand cross-links
induced by cisplatin
To be able to compare the repair characteristics of both
mutants versus the parental cell line, we then studied the re-
moval of interstrand cross-links induced by a di¡erent cross-
linking agent, from the rRNA gene of V79, V-H4 and V-C8
cells. Cells were treated with 200 WM cisplatin for 5 h, when
cisplatin concentrations achieved in plasma of humans varies
from 10 to 60 WM. Since none of the cell lines demonstrated
signi¢cant replication within the time of the experiment, we
only used the parental DNA in subsequent repair assays.
A representative autoradiogram, Fig. 3A, shows the forma-
tion (t = 0 h) and the removal (t = 24 h and 48 h) of cisplatin-
induced cross-links within a 20-kb fragment of the rRNA of
the parental DNA of V79, V-H4 and V-C8 cells. The treat-
ment induced similar numbers of interstrand cross-links
(about 0.8 cross-link/10 kb fragment) in the three cell lines
(Fig. 3A) and the removal of these cross-links was e¡ective
within the three cell lines (Fig. 3A). Data from the cisplatin
interstrand cross-links experiments are compiled in Fig. 3B:
about 40^45% of the cross-links were repaired at t = 24 h and
50^55% at t = 48 h (Fig. 3A,B). The extent of cisplatin cross-
link removal was also quanti¢ed once after 4 and 8 h of repair
incubation. We found 16^20% repair within 4 h after exposure
to the drug and 28^35% repair within 8 h for the three cell
lines (data not shown). Unlike MMC-induced cross-links, cis-
platin-induced cross-links were signi¢cantly removed from the
rRNA sequence during the repair kinetics. However, there
was no signi¢cant di¡erence between resistant and sensitive
cell lines regarding the repair of the cisplatin-induced inter-
strand cross-links, indicating that V-H4 and V-C8 cells are
not de¢cient in the excision repair of these lesions.
4. Discussion
There are many mechanisms by which hypersensitivity to
bifunctional agents can be achieved in cells. The ability to
remove DNA interstrand cross-links may be an important
factor contributing to MMC and cisplatin sensitivities. In
this report, we have compared the cross-link formation and
removal characteristics in a de¢ned gene sequence of MMC-
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Fig. 3. Formation and repair of cisplatin-induced interstrand cross-
links in the rRNA gene of hamster cells. A: Representative autora-
diogram of Southern blot of HindIII genomic fragments, isolated
from V79, V-H4 and V-C8 cell lines treated with 200 WM cisplatin
for 5 h, and hybridized with 32P-labeled probe for the rRNA region.
Cross-link detection in parental DNA is shown following incubation
at 0, 24, and 48 h with denaturation by NaOH. DS, double-
stranded DNA. SS, single-stranded DNA. Cont, non-damaged
DNA. B: Data were derived from quantitation of Southern blots
using a PhosphorImager and ImageQuant software (Molecular Dy-
namics) and are presented as mean values þ S.E. from three biologi-
cal experiments, with two to four sets of gel electrophoresis for each
experiment. Values were determined from scans of double-stranded
DNA versus total (single- plus double-stranded) DNA for each time
point.
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hypersensitive V-H4 and V-C8 cell mutants with those of the
resistant parental V79 cell line. Using a gene-speci¢c detection
assay, we measured equivalent amounts of MMC-induced
DNA interstrand cross-links at the level of the rRNA gene
in V79, V-H4 and V-C8 cells. These ¢ndings argue against
di¡erences in drug uptake, metabolic activation or detoxi¢ca-
tion pathways being responsible for di¡erential MMC toxicity
in the three cell lines, since di¡erences in any of these proc-
esses are expected to be re£ected in di¡erent levels of DNA
cross-linking in cell lines [20,21]. Thus, the enhanced sensitiv-
ity of V-H4 and V-C8 cells to MMC is rather due to cellular
processes downstream of the initial DNA damage formation.
We found no evidence for signi¢cant repair of MMC cross-
links at the level of the rRNA gene of either parental or
mutant cell lines. Therefore, MMC-induced interstrand
cross-links can subsist in hamster cells for extended periods
of time. These data indicate that persistence of DNA inter-
strand cross-links is not responsible for the di¡erential toxicity
of MMC towards V-H4 and V-C8 cells. Moreover, we have
shown that MMC-induced cross-links, originally formed in
parental DNA, were also associated with newly replicated
DNA. These ¢ndings are consistent with results from studies
which also reported slow repair kinetics of MMC-induced
cross-links [22] and distribution of cross-links in both parental
and daughter DNA of human cells [23]. The presence of DNA
interstrand cross-links in the replicated DNA after MMC
treatment might be a consequence of a recombinational mech-
anism occurring during replication past cross-links, or a con-
version of monofunctional MMC adducts to interstrand
cross-links during the repair kinetics. Using an excision re-
pair-de¢cient cell line, we have shown that, in addition to a
¢rst and rapid induction of MMC interstrand cross-links,
there is a delayed two-step mechanism for MMC cross-link
formation. The ¢rst alkylation step would yield monoadducts,
and the second alkylation biadducts after some period of time
[24]. These ¢ndings may explain discrepancies found in the
literature concerning MMC interstrand cross-link repair stud-
ies in normal and FA cells [25,26], since cross-link detection
would be the result of a combination of delayed formation
and incision during the repair process. We therefore con-
cluded that delayed formation associated with slow repair
may explain the persistence of MMC-induced cross-links in
V79, V-H4 and V-C8 hamster cell lines.
To be able to compare the repair characteristics of V-H4
and V-C8 cell mutants with those of the V79 parental cell line,
we next examined the removal of cisplatin-induced cross-links
from the rRNA gene. It was previously reported that cispla-
tin-induced interstrand cross-links are repaired equally e⁄-
ciently in RNA polymerase II-transcribed genes, such as the
DHFR gene, and RNA polymerase I-transcribed genes, such
as the rRNA gene [27,28]. Our present results show that ex-
cision repair of cisplatin interstrand cross-links is e⁄cient in
resistant as well as in sensitive cell lines. This indicates that V-
H4 and V-C8 hypersensitive mutants are not de¢cient in re-
pair of interstrand cross-links, such as MMC-hypersensitive
mutants of complementation group 1, which are defective in
nucleotide excision repair and unable to excise DNA inter-
strand cross-links [5].
Finally, hypersensitive V-H4 and V-C8 cells could not be
di¡erentiated from resistant V79 cells by comparing their
MMC- or cisplatin-induced cross-link repair e⁄ciencies at
the level of the rRNA gene. Therefore, we concluded that a
defect in DNA excision repair of interstrand cross-links was
not responsible for the cytotoxic e¡ects of MMC and cisplatin
in V-H4 and V-C8 hamster cells. Studies are under way in our
laboratory to identify the cellular response(s) to cross-linking
agents that is defective in these two hypersensitive mutants.
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